• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ability of community pharmacists to independently perform CLIA-waived testing - A multistate legal review.社区药剂师独立开展临床实验室改进修正案(CLIA)豁免检测的能力——一项多州法律审查
Explor Res Clin Soc Pharm. 2021 May 8;2:100024. doi: 10.1016/j.rcsop.2021.100024. eCollection 2021 Jun.
2
Pharmacy-based CLIA-waived testing in the United States: Trends, impact, and the road ahead.美国基于药房的 CLIA 豁免检测:趋势、影响和未来之路。
Res Social Adm Pharm. 2024 Jun;20(6):146-151. doi: 10.1016/j.sapharm.2024.03.003. Epub 2024 Mar 15.
3
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects.社区药房环境中的分子即时检测:现状与未来前景。
Expert Rev Mol Diagn. 2022 Oct 31:1-14. doi: 10.1080/14737159.2022.2139178.
4
Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.传染病的即时检测:社区药房中的机遇、障碍及考量因素
J Am Pharm Assoc (2003). 2014 Mar-Apr;54(2):163-71. doi: 10.1331/JAPhA.2014.13167.
5
U.S. community pharmacies as CLIA-waived facilities: Prevalence, dispersion, and impact on patient access to testing.作为临床实验室改进修正案(CLIA)豁免机构的美国社区药房:患病率、分布情况及其对患者检测可及性的影响。
Res Social Adm Pharm. 2016 Jul-Aug;12(4):614-21. doi: 10.1016/j.sapharm.2015.09.006. Epub 2015 Sep 28.
6
Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities.2019年冠状病毒病对作为临床实验室改进修正案豁免设施的社区药房流行率的影响。
Res Social Adm Pharm. 2021 Sep;17(9):1574-1578. doi: 10.1016/j.sapharm.2020.12.003. Epub 2020 Dec 15.
7
Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.利用基于药房的传染病即时检测服务开展药房与公共卫生合作的潜力。
J Public Health Manag Pract. 2017 Nov/Dec;23(6):593-600. doi: 10.1097/PHH.0000000000000482.
8
The Community Pharmacy Technician's Role in the Changing Pharmacy Practice Space.社区药房技术员在不断变化的药房实践环境中的角色。
Innov Pharm. 2020 Apr 30;11(2). doi: 10.24926/iip.v11i2.3325. eCollection 2020.
9
Pharmacist-led Smoking-Cessation Services in the United States - A Multijurisdictional Legal Analysis.美国药剂师主导的戒烟服务——多辖区法律分析
Innov Pharm. 2022 Apr 2;13(1). doi: 10.24926/iip.v13i1.4643. eCollection 2022.
10
Point-of-Care Testing in Community Pharmacies: Keys to Success From Pennsylvania Pharmacists.社区药房的即时检测:宾夕法尼亚州药剂师的成功秘诀
J Pharm Pract. 2018 Dec;31(6):629-635. doi: 10.1177/0897190017735243. Epub 2017 Oct 15.

引用本文的文献

1
Exploring the Evolving Role of Pharmaceutical Services in Community Pharmacies: Insights from the USA, England, and Portugal.探索社区药房中药剂服务不断演变的角色:来自美国、英国和葡萄牙的见解。
Healthcare (Basel). 2025 Jul 23;13(15):1786. doi: 10.3390/healthcare13151786.
2
State Variation in Uptake of Pharmacy-Based CLIA-Waived Testing: Impact of Laws and Regulations.基于药房的临床实验室改进修正案(CLIA)豁免检测的采用情况的州差异:法律法规的影响
J Pharm Technol. 2024 Dec 23:87551225241306678. doi: 10.1177/87551225241306678.

本文引用的文献

1
U.S. community pharmacies as CLIA-waived facilities: Prevalence, dispersion, and impact on patient access to testing.作为临床实验室改进修正案(CLIA)豁免机构的美国社区药房:患病率、分布情况及其对患者检测可及性的影响。
Res Social Adm Pharm. 2016 Jul-Aug;12(4):614-21. doi: 10.1016/j.sapharm.2015.09.006. Epub 2015 Sep 28.

社区药剂师独立开展临床实验室改进修正案(CLIA)豁免检测的能力——一项多州法律审查

Ability of community pharmacists to independently perform CLIA-waived testing - A multistate legal review.

作者信息

Doucette Joseph, Lavino Joseph

机构信息

Massachusetts College of Pharmacy and Health Sciences University, Candidate for Doctor of Pharmacy-Accelerated '21, 1260 Elm Street, Manchester, NH 03101, USA.

Massachusetts College of Pharmacy and Health Sciences University, 179 Longwood Ave, Boston, MA 02115, USA.

出版信息

Explor Res Clin Soc Pharm. 2021 May 8;2:100024. doi: 10.1016/j.rcsop.2021.100024. eCollection 2021 Jun.

DOI:10.1016/j.rcsop.2021.100024
PMID:35481127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9031441/
Abstract

The scope of practice of community pharmacy has continued in its evolution into a clinically focused profession. A critical component to pharmacist clinical offerings in the United States is the performance of Clinical Laboratory Improvement Amendments ("CLIA") waived tests. However, state laws and regulations greatly influence a pharmacist's ability to perform a CLIA-waived test. Based on this variability and lack of clarity in state laws and regulations, a legal review was performed, which focused on the following themes: 1) states which currently allow a pharmacist to independently perform CLIA-waived testing; 2) of those states, which states impose restrictions on the scope of CLIA-waived tests that may be independently performed by a pharmacist; and 3) states that impose restrictions on the ability of a pharmacist to independently perform CLIA-waived testing. Federal laws already exist that allow individuals, pursuant to certification, to perform CLIA-waived testing. This allowance presumably includes pharmacists if they follow federal law. However, some states regulate and restrict this area for pharmacists, contrary to these federal laws. States may see an improvement in patient care and further expand the practice of pharmacy by limiting restrictions on pharmacists to perform CLIA-waived tests and following federal allowances.

摘要

社区药房的业务范围已持续发展成为一个以临床为重点的专业领域。在美国,药剂师临床服务的一个关键组成部分是进行临床实验室改进修正案(“CLIA”)豁免检测。然而,州法律法规极大地影响了药剂师进行CLIA豁免检测的能力。基于州法律法规的这种差异性和不明确性,进行了一次法律审查,审查集中在以下几个主题:1)目前允许药剂师独立进行CLIA豁免检测的州;2)在这些州中,哪些州对药剂师可独立进行的CLIA豁免检测范围施加了限制;3)对药剂师独立进行CLIA豁免检测的能力施加限制的州。联邦法律已经允许个人在获得认证后进行CLIA豁免检测。如果药剂师遵守联邦法律,这种许可大概也包括他们。然而,一些州违反这些联邦法律,对药剂师在这一领域进行监管和限制。各州可以通过限制对药剂师进行CLIA豁免检测的限制并遵循联邦许可,来改善患者护理并进一步扩大药房业务范围。